Behavioral
Transcendental Meditation (TM)
Total Trials
4
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(50%)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 3 finished
Non-Completion Rate
100.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Terminated(3)
Detailed Status
Terminated2
Withdrawn1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
withdrawn125%
terminated250%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Women's Healthy Aging and Menopause; (WHAM)
NCT07314827
terminatednot_applicable
Transcendental Meditation in Veterans and First Responders With PTSD
NCT05645042
terminatednot_applicable
Data-driven Approaches to Healthcare Provider Resilience & Burnout During COVID-19
NCT04922632
withdrawn
TM Meditation in Children With ADD/ADHD
NCT03817593
Clinical Trials (4)
Showing 4 of 4 trials
NCT07314827Not Applicable
Women's Healthy Aging and Menopause; (WHAM)
NCT05645042Not Applicable
Transcendental Meditation in Veterans and First Responders With PTSD
NCT04922632Not Applicable
Data-driven Approaches to Healthcare Provider Resilience & Burnout During COVID-19
NCT03817593
TM Meditation in Children With ADD/ADHD
All 4 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 4